MB Fund Podcast: Revolutionary Investment Opportunities


Get ready to dive into the future of investing with us this week! Join us in this week’s podcast as Nucleus Wealth’s Chief Investment Officer Damien Klassen and Head of Advice Samuel Kerr explore the most exciting investment themes set to redefine the next few years.

We’re talking about groundbreaking trends that every savvy investor needs to watch:

• Electrification: as we move to a world powered by clean energy, change is at hand. Both opportunities and traps abound.
• Obesity Drugs: We’re investigating the revolutionary drugs poised to tackle the global obesity epidemic.
• Onshoring & Robotics: Witness the rebirth of manufacturing with cutting-edge robotics. Find out how onshoring is getting a high-tech makeover.
• AI: Step into the world of Artificial Intelligence. We’re uncovering how AI is reshaping industries and creating opportunities.
• Cloud Computing: Soar into the cloud. Learn about the tech giants leading the charge in cloud computing and how it’s transforming the digital landscape.
• Energy: Power up with insights into the dynamic energy sector. From traditional fuels to renewable sources, discover the energy investments lighting up the market.

Don’t miss out! Tune in, and let’s unlock the potential of your portfolio with these game-changing investment trends. Subscribe and hit the bell icon to stay ahead in the investment game with us!


View the presentation slides

Can’t make it to the live series? Catch up on the content via Podcasts or our recorded Videos.

Samuel Kerr is a Senior Financial Adviser at the MacroBusiness Fund, which is powered by Nucleus Wealth.

Fill out my online form.


The information on this blog contains general information and does not take into account your personal objectives, financial situation or needs. Past performance is not an indication of future performance. Samuel Kerr is an Authorised Representative of Nucleus Advice Pty Limited, Australian Financial Services Licensee 515796. And Nucleus Wealth is a Corporate Authorised Representative of Nucleus Advice Pty Ltd.